Richardson Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
3,525
+2,975
+541% +$171K 0.12% 164
2026
Q1
$33.4K Buy
550
+110
+25% +$6.41K 0.02% 359
2025
Q4
$23.7K Buy
440
+10
+2% +$481 0.01% 388
2025
Q3
$19.4K Buy
430
+100
+30% +$4.67K 0.01% 379
2025
Q2
$15.7K Sell
330
-508
-61% -$24.9K 0.01% 360
2025
Q1
$51.1K Sell
838
-4
-0.5% -$233 0.04% 242
2024
Q4
$47.2K Buy
+842
New +$47K 0.03% 260
2024
Q2
Sell
-25
Closed -$1.08K 592
2024
Q1
$1.08K Buy
+25
New +$1.27K ﹤0.01% 541

Other funds holding BMY

Richardson Financial Services's BMY Position: Q2 2026 in Review

Richardson Financial Services increased its Bristol-Myers Squibb (BMY) stake by 541% in Q2 2026, buying an estimated $171K and bringing the position to 3,525 shares worth $203K. The position accounts for 0.12% of the portfolio, ranked #164.

Richardson Financial Services first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Richardson Financial Services held 3,525 shares of Bristol-Myers Squibb worth $203K as of Q2 2026.
  • Richardson Financial Services bought 2,975 Bristol-Myers Squibb shares in Q2 2026, an estimated $171K.
  • Bristol-Myers Squibb made up 0.12% of Richardson Financial Services's portfolio in Q2 2026, its #164 holding.
  • Richardson Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.